Showing results (1261-1270 of 2,232) with videos related to

Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|February 24, 2001
A new in vivo and in vitro B cell lymphoma model, pi-BCL1T Illidge, J Honeychurch, W Howatt, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Effect of gold on survival of tumor-bearing miceH Kamei, T Koide, T Kojima, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1997
Various functions of PBMC from colon cancer patients are not decreased compared to healthy blood donorsP Afzelius, H J Nielsen
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1997
Influence of flavonoids on cell cycle phase as analyzed by flow-cytometryT Koide, H Kamei, Y Hashimoto, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Dose distribution of low-dose subcutaneous recombinant interleukin-2 affects the secondary release of interferon-gamma in vivoM Meffert, S Duensing, J Atzpodien
Cancer Biotherapy & Radiopharmaceuticals|October 1, 1996
Establishment of a rat colonic carcinoma model for study of immunoreagents against the human tumor-associated TAG72 antigenJ Xiang, T Moyana, G Matte, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1996
Synthetic thymic fraction 5: effects of high dose administration on circulating lymphocytes in patientsG Cartei, G Sava, G Salerno, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1996
Treatment of stage D2 hormone refractory carcinoma of the prostate with 5-fluorouracil and Roferon-A: a Southwest Oncology Group studyM E Marshall, M Wolf, M O'Rourke, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 1, 1996
Influence of OH group and sugar bonded to flavonoids on flavonoid-mediated suppression of tumor growth in vitroH Kamei, T Kojima, T Koide, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 1, 1996
Antitumor effect of hydrolyzed anthocyanin from grape rinds and red riceT Koide, H Kamei, Y Hashimoto, et al.
Pageof 224